Humana Inc reported Q3 adjusted EPS of $7.78, beating the consensus of $7.16, and revenue of $26.42 billion, up from $22.78 billion a year ago. However, the company's profits fell 30% to $830 million. Despite a strong quarter, shares fell due to disappointment that Humana did not increase its full-year guide. The company's caution relates to elevated demand for non-urgent surgeries that may constrain Q4 results. Humana reaffirms adjusted EPS guidance of at least $28.25 versus the consensus of $28.3.